Studies
A Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers
A Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers
Request Access
Overview
Selected Publications (1)
Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.
Benjamin Y Jin, T. Campbell, Lindsey M Draper, et al.. (2018). JCI insight. Cited 138 times.
https://doi.org/10.1172/jci.insight.99488
